Meters change from baseline in 6MWD · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Endurance time on constant load ergometry (s) · people with ILD
1 finding from 1 review
Change in incremental shuttle walk distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change from baseline in 6MWT (metres) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Exercise capacity · patients with chronic obstructive pulmonary disease
1 finding from 1 review
FEV1 · adults with asthma
1 finding from 1 review
Intervention not reported
Adverse events-serious Fluticasone/salmeterol (FPS) versus fluticasone (FP) · patients with COPD
The intervention showed no clear difference in adverse events-serious Fluticasone/salmeterol (FPS) versus… (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events-serious Mometasone/formoterol (MF/F) versus Mometasone (MF) · patients with COPD
The intervention showed no clear difference in adverse events-serious Mometasone/formoterol (MF/F) versus… (low certainty).
1 finding from 1 review
Change in 6‐minute walking distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
99 participants
Moderate
Exercise capacity · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
30 participants
High
Exercise capacity (change from baseline) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
30 participants
High
Change in 6‐minute walking distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
62 participants
Moderate
Exercise capacity · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
59 participants
Low
Exercise capacity (change from baseline) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
59 participants
Moderate
Intervention not reported
Functional exercise capacity (change from baseline; mixed population) ‐ 6‐minute walk test metres · patients with stable chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Functional exercise capacity ‐ 6‐minute walk test (mixed population) metres · stable chronic obstructive pulmonary disease
1 finding from 1 review
Change in 6‐minute walking distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Six‐minute walk distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in 6‐minute walking distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
All‐cause mortality · children with chronic asthma
1 finding from 1 review